COVAXIN overall 77.8% effective in Phase-3 trial : Bharat Biotech
  • 3 years ago
Bharat Biotech's Covaxin is overall 77.8 percent effective against Covid, the vaccine maker tweeted today, citing the data from the third phase of clinical trials.
Recommended